Advancements in stem cells treatment of skeletal muscle wasting

Frontiers in Physiology

Volumn 5 FEB, Issue , 2014, Pages

  Meregalli, Mirella ^a   Farini, Andrea ^a   Sitzia, Clementina ^a   Torrente, Yvan ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Fibrosis; Inflammation; Muscle wasting; Myogenic stem cell; Stem cell niche

Indexed keywords

CD133 ANTIGEN;

CELL FATE; EMBRYONIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MESOANGIOBLAST; MUSCLE ATROPHY; MUSCLE DERIVED STEM CELL; MUSCLE HYPERTROPHY; MUSCLE REGENERATION; MYOFIBROSIS; MYOSITIS; NONHUMAN; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; REVIEW; SATELLITE CELL NICHE; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; STEM CELL NICHE; STEM CELL TRANSPLANTATION;

EID: 84895474008     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00048     Document Type: Review

References (173)

1. Abbott, A. (2003). Cell culture: biology's new dimension. Nature 424, 870-872. doi: 10.1038/424870a.
2. Adams, G. B., Martin, R. P., Alley, I. R., Chabner, K. T., Cohen, K. S., Calvi, L. M., et al. (2007). Therapeutic targeting of a stem cell niche. Nat. Biotechnol. 25, 238-243. doi: 10.1038/nbt1281.
3. Alessandri, G., Pagano, S., Bez, A., Benetti, A., Pozzi, S., Iannolo, G., et al. (2004). Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364, 1872-1883. doi: 10.1016/S0140-6736(04)17443-6.
4. Alhadlaq, A., and Mao, J. J. (2004). Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev. 13, 436-448. doi: 10.1089/scd.2004.13.436.
5. Amit, M., and Itskovitz-Eldor, J. (2002). Derivation and spontaneous differentiation of human embryonic stem cells. J. Anat. 200, 225-232. doi: 10.1046/j.1469-7580.2002.00032.x.
6. Amthor, H., Huang, R., Mckinnell, I., Christ, B., Kambadur, R., Sharma, M., et al. (2002). The regulation and action of myostatin as a negative regulator of muscle development during avian embryogenesis. Dev. Biol. 251, 241-257. doi: 10.1006/dbio.2002.0812.
7. Andrews, P. W., Casper, J., Damjanov, I., Duggan-Keen, M., Giwercman, A., Hata, J., et al. (1996). Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int. J. Cancer 66, 806-816. doi: 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO;2-0.
8. Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., Van Rooijen, N., Plonquet, A., et al. (2007). Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204, 1057-1069. doi: 10.1084/jem.20070075.
9. Backman, E., and Henriksson, K. G. (1995). Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy. Neuromuscul. Disord. 5, 233-241. doi: 10.1016/0960-8966(94)00048-E.
10. Bamman, M. M., Shipp, J. R., Jiang, J., Gower, B. A., Hunter, G. R., Goodman, A. Jr., et al. (2001). Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am. J. Physiol. Endocrinol. Metab. 280, E383-E390.
11. Barberi, T., Bradbury, M., Dincer, Z., Panagiotakos, G., Socci, N. D., and Studer, L. (2007). Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat. Med. 13, 642-648. doi: 10.1038/nm1533.
12. Benchaouir, R., Meregalli, M., Farini, A., D'antona, G., Belicchi, M., Goyenvalle, A., et al. (2007). Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 1, 646-657. doi: 10.1016/j.stem.2007.09.016.
13. Beyer Nardi, N., and Da Silva Meirelles, L. (2006). Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb. Exp. Pharmacol. 174, 249-282. doi: 10.1007/978-3-540-77855-4_11.
14. Bhagavati, S., and Xu, W. (2005). Generation of skeletal muscle from transplanted embryonic stem cells in dystrophic mice. Biochem. Biophys. Res. Commun. 333, 644-649. doi: 10.1016/j.bbrc.2005.05.135.
15. Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K., Nunez, L., Clarke, B. A., et al. (2001). Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708. doi: 10.1126/science.1065874.
16. Bogdanovich, S., Krag, T. O., Barton, E. R., Morris, L. D., Whittemore, L. A., Ahima, R. S., et al. (2002). Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418-421. doi: 10.1038/nature01154.
17. Brack, A. S., Conboy, I. M., Conboy, M. J., Shen, J., and Rando, T. A. (2008). A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2, 50-59. doi: 10.1016/j.stem.2007.10.006.
18. Brack, A. S., and Rando, T. A. (2007). Intrinsic changes and extrinsic influences of myogenic stem cell function during aging. Stem Cell Rev. 3, 226-237. doi: 10.1007/s12015-007-9000-2.
19. Brunelli, S., and Rovere-Querini, P. (2008). The immune system and the repair of skeletal muscle. Pharmacol. Res. 58, 117-121. doi: 10.1016/j.phrs.2008.06.008.
20. Buckingham, M., Bajard, L., Chang, T., Daubas, P., Hadchouel, J., Meilhac, S., et al. (2003). The formation of skeletal muscle: from somite to limb. J. Anat. 202, 59-68. doi: 10.1046/j.1469-7580.2003.00139.x.
21. Burkin, D. J., and Kaufman, S. J. (1999). The alpha7beta1 integrin in muscle development and disease. Cell Tissue Res. 296, 183-190. doi: 10.1007/s004410051279.
22. Cai, B., Spencer, M. J., Nakamura, G., Tseng-Ong, L., and Tidball, J. G. (2000). Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. Am. J. Pathol. 156, 1789-1796. doi: 10.1016/S0002-9440(10)65050-X.
23. Carpenter, M. K., Rosler, E., and Rao, M. S. (2003). Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 5, 79-88. doi: 10.1089/153623003321512193.
24. Carr, A. J., Vugler, A. A., Hikita, S. T., Lawrence, J. M., Gias, C., Chen, L. L., et al. (2009). Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS ONE 4:e8152. doi: 10.1371/journal.pone.0008152.
25. Cassano, M., Quattrocelli, M., Crippa, S., Perini, I., Ronzoni, F., and Sampaolesi, M. (2009). Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. J. Muscle Res. Cell Motil. 30, 243-253. doi: 10.1007/s10974-010-9204-y.
26. Cerletti, M., Jurga, S., Witczak, C. A., Hirshman, M. F., Shadrach, J. L., Goodyear, L. J., et al. (2008). Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 134, 37-47. doi: 10.1016/j.cell.2008.05.049.
27. Clop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibe, B., et al. (2006). A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat. Genet. 38, 813-818. doi: 10.1038/ng1810.
28. Collins, C. A., Olsen, I., Zammit, P. S., Heslop, L., Petrie, A., Partridge, T. A., et al. (2005). Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122, 289-301. doi: 10.1016/j.cell.2005.05.010.
29. Conboy, I. M., Conboy, M. J., Smythe, G. M., and Rando, T. A. (2003). Notch-mediated restoration of regenerative potential to aged muscle. Science 302, 1575-1577. doi: 10.1126/science.1087573.
30. Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L., and Rando, T. A. (2005). Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433, 760-764. doi: 10.1038/nature03260.
31. Conboy, I. M., and Rando, T. A. (2002). The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 3, 397-409. doi: 10.1016/S1534-5807(02)00254-X.
32. Conrad, S., Renninger, M., Hennenlotter, J., Wiesner, T., Just, L., Bonin, M., et al. (2008). Generation of pluripotent stem cells from adult human testis. Nature 456, 344-349. doi: 10.1038/nature07404.
33. Constantin, G., Marconi, S., Rossi, B., Angiari, S., Calderan, L., Anghileri, E., et al. (2009). Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 27, 2624-2635. doi: 10.1002/stem.194.
34. Cosgrove, B. D., Sacco, A., Gilbert, P. M., and Blau, H. M. (2009). A home away from home: challenges and opportunities in engineering in vitro muscle satellite cell niches. Differentiation 78, 185-194. doi: 10.1016/j.diff.2009.08.004.
35. Cossu, G., and Sampaolesi, M. (2007). New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol. Med. 13, 520-526. doi: 10.1016/j.molmed.2007.10.003.
36. Cukierman, E., Pankov, R., Stevens, D. R., and Yamada, K. M. (2001). Taking cell-matrix adhesions to the third dimension. Science 294, 1708-1712. doi: 10.1126/science.1064829.
37. Darabi, R., Arpke, R. W., Irion, S., Dimos, J. T., Grskovic, M., Kyba, M., et al. (2012). Human ES-and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 10, 610-619. doi: 10.1016/j.stem.2012.02.015.
38. Darabi, R., Baik, J., Clee, M., Kyba, M., Tupler, R., and Perlingeiro, R. C. (2009). Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy. Exp. Neurol. 220, 212-216. doi: 10.1016/j.expneurol.2009.08.002.
39. Darabi, R., Gehlbach, K., Bachoo, R. M., Kamath, S., Osawa, M., Kamm, K. E., et al. (2008a). Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat. Med. 14, 134-143. doi: 10.1038/nm1705.
40. Darabi, R., Santos, F. N., and Perlingeiro, R. C. (2008b). The therapeutic potential of embryonic and adult stem cells for skeletal muscle regeneration. Stem Cell Rev. 4, 217-225. doi: 10.1007/s12015-008-9023-3.
41. Darabi, R., Santos, F. N., Filareto, A., Pan, W., Koene, R., Rudnicki, M. A., et al. (2011). Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors. Stem Cells 29, 777-790. doi: 10.1002/stem.625.
42. De Bari, C., Dell'accio, F., Tylzanowski, P., and Luyten, F. P. (2001). Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44, 1928-1942. doi: 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P.
43. De Bari, C., Dell'accio, F., Vandenabeele, F., Vermeesch, J. R., Raymackers, J. M., and Luyten, F. P. (2003). Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J. Cell Biol. 160, 909-918. doi: 10.1083/jcb.200212064.
44. De Senzi Moraes Pinto, R., Ferretti, R., Moraes, L. H., Neto, H. S., Marques, M. J., and Minatel, E. (2013). N-acetylcysteine treatment reduces TNF-alpha levels and myonecrosis in diaphragm muscle of mdx mice. Clin. Nutr. 32, 472-475. doi: 10.1016/j.clnu.2012.06.001.
45. Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., et al. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221. doi: 10.1126/science.1158799.
46. Dykstra, B., Ramunas, J., Kent, D., Mccaffrey, L., Szumsky, E., Kelly, L., et al. (2006). High-resolution video monitoring of hematopoietic stem cells cultured in single-cell arrays identifies new features of self-renewal. Proc. Natl. Acad. Sci. U.S.A. 103, 8185-8190. doi: 10.1073/pnas.0602548103.
47. Ebert, A. D., Yu, J., Rose, F. F. Jr., Mattis, V. B., Lorson, C. L., Thomson, J. A., et al. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277-280. doi: 10.1038/nature07677.
48. Egawa, N., Kitaoka, S., Tsukita, K., Naitoh, M., Takahashi, K., Yamamoto, T., et al. (2012). Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 4, 145ra104. doi: 10.1126/scitranslmed.3004052.
49. Engler, A. J., Griffin, M. A., Sen, S., Bonnemann, C. G., Sweeney, H. L., and Discher, D. E. (2004). Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J. Cell Biol. 166, 877-887. doi: 10.1083/jcb.200405004.
50. Engler, A. J., Sen, S., Sweeney, H. L., and Discher, D. E. (2006). Matrix elasticity directs stem cell lineage specification. Cell 126, 677-689. doi: 10.1016/j.cell.2006.06.044.
51. Fadok, V. A., Bratton, D. L., Guthrie, L., and Henson, P. M. (2001). Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J. Immunol. 166, 6847-6854.
52. Fan, V. H., Tamama, K., Au, A., Littrell, R., Richardson, L. B., Wright, J. W., et al. (2007). Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 25, 1241-1251. doi: 10.1634/stemcells.2006-0320.
53. Farini, A., Razini, P., Erratico, S., Torrente, Y., and Meregalli, M. (2009). Cell based therapy for Duchenne muscular dystrophy. J. Cell Physiol. 221, 526-534. doi: 10.1002/jcp.21895.
54. Filareto, A., Parker, S., Darabi, R., Borges, L., Iacovino, M., Schaaf, T., et al. (2013). An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells. Nat Commun 4, 1549. doi: 10.1038/ncomms2550.
55. Fiorina, P., Jurewicz, M., Augello, A., Vergani, A., Dada, S., La Rosa, S., et al. (2009). Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J. Immunol. 183, 993-1004. doi: 10.4049/jimmunol.0900803.
56. Flanigan, K. M., Campbell, K., Viollet, L., Wang, W., Gomez, A. M., Walker, C. M., et al. (2013). Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect. Hum. Gene Ther. 24, 797-806. doi: 10.1089/hum.2013.092.
57. Folkman, J., and Moscona, A. (1978). Role of cell shape in growth control. Nature 273, 345-349. doi: 10.1038/273345a0.
58. Galvez, B. G., Sampaolesi, M., Brunelli, S., Covarello, D., Gavina, M., Rossi, B., et al. (2006). Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J. Cell Biol. 174, 231-243. doi: 10.1083/jcb.200512085.
59. Gang, E. J., Jeong, J. A., Hong, S. H., Hwang, S. H., Kim, S. W., Yang, I. H., et al. (2004). Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 22, 617-624. doi: 10.1634/stemcells.22-4-617.
60. Gates, C. B., Karthikeyan, T., Fu, F., and Huard, J. (2008). Regenerative medicine for the musculoskeletal system based on muscle-derived stem cells. J. Am. Acad. Orthop. Surg. 16, 68-76.
61. Golding, J. P., Calderbank, E., Partridge, T. A., and Beauchamp, J. R. (2007). Skeletal muscle stem cells express anti-apoptotic ErbB receptors during activation from quiescence. Exp. Cell. Res. 313, 341-356. doi: 10.1016/j.yexcr.2006.10.019.
62. Gordon, S. (2003). Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35. doi: 10.1038/nri978.
63. Gordon, S., and Taylor, P. R. (2005). Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964. doi: 10.1038/nri1733.
64. Goudenege, S., Lebel, C., Huot, N. B., Dufour, C., Fujii, I., Gekas, J., et al. (2012). Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation. Mol. Ther. 20, 2153-2167. doi: 10.1038/mt.2012.188.
65. Grounds, M. D. (1987). Phagocytosis of necrotic muscle in muscle isografts is influenced by the strain, age, and sex of host mice. J. Pathol. 153, 71-82. doi: 10.1002/path.1711530110.
66. Grounds, M. D., Sorokin, L., and White, J. (2005). Strength at the extracellular matrix-muscle interface. Scand J Med Sci Sports 15, 381-391. doi: 10.1111/j.1600-0838.2005.00467.x.
67. Gu, F., Zhang, L., Teply, B. A., Mann, N., Wang, A., Radovic-Moreno, A. F., et al. (2008). Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc. Natl. Acad. Sci. U.S.A. 105, 2586-2591. doi: 10.1073/pnas.0711714105.
68. Gussoni, E., Blau, H. M., and Kunkel, L. M. (1997). The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. 3, 970-977. doi: 10.1038/nm0997-970.
69. Hanna, J., Wernig, M., Markoulaki, S., Sun, C. W., Meissner, A., Cassady, J. P., et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923. doi: 10.1126/science.1152092.
70. Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D. H., Bronner-Fraser, M., et al. (2003). Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U.S.A. 100, 15178-15183. doi: 10.1073/pnas.2036535100.
71. Hodgetts, S., Radley, H., Davies, M., and Grounds, M. D. (2006). Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice. Neuromuscul. Disord. 16, 591-602. doi: 10.1016/j.nmd.2006.06.011.
72. Hoffman, L. M., and Carpenter, M. K. (2005). Characterization and culture of human embryonic stem cells. Nat. Biotechnol. 23, 699-708. doi: 10.1038/nbt1102.
73. Horsley, V., Jansen, K. M., Mills, S. T., and Pavlath, G. K. (2003). IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113, 483-494. doi: 10.1016/S0092-8674(03)00319-2.
74. Iacovino, M., Bosnakovski, D., Fey, H., Rux, D., Bajwa, G., Mahen, E., et al. (2011). Inducible cassette exchange: a rapid and efficient system enabling conditional gene expression in embryonic stem and primary cells. Stem Cells 29, 1580-1588. doi: 10.1002/stem.715.
75. Ichim, T. E., Alexandrescu, D. T., Solano, F., Lara, F., Campion Rde, N., Paris, E., et al. (2010). Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol. 260, 75-82. doi: 10.1016/j.cellimm.2009.10.006.
76. Irintchev, A., Zeschnigk, M., Starzinski-Powitz, A., and Wernig, A. (1994). Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles. Dev. Dyn. 199, 326-337. doi: 10.1002/aja.1001990407.
77. Irvine, D. J., Hue, K. A., Mayes, A. M., and Griffith, L. G. (2002). Simulations of cell-surface integrin binding to nanoscale-clustered adhesion ligands. Biophys. J. 82, 120-132. doi: 10.1016/S0006-3495(02)75379-4.
78. Jackson, W. M., Nesti, L. J., and Tuan, R. S. (2010). Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin. Biol. Ther. 10, 505-517. doi: 10.1517/14712591003610606.
79. Klingler, W., Jurkat-Rott, K., Lehmann-Horn, F., and Schleip, R. (2012). The role of fibrosis in Duchenne muscular dystrophy. Acta Myol. 31, 184-195.
80. Kloxin, A. M., Kasko, A. M., Salinas, C. N., and Anseth, K. S. (2009). Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 324, 59-63. doi: 10.1126/science.1169494.
81. Kuang, S., Gillespie, M. A., and Rudnicki, M. A. (2008). Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2, 22-31. doi: 10.1016/j.stem.2007.12.012.
82. Kuang, S., Kuroda, K., Le Grand, F., and Rudnicki, M. A. (2007). Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129, 999-1010. doi: 10.1016/j.cell.2007.03.044.
83. Kuraitis, D., Giordano, C., Ruel, M., Musaro, A., and Suuronen, E. J. (2012). Exploiting extracellular matrix-stem cell interactions: a review of natural materials for therapeutic muscle regeneration. Biomaterials 33, 428-443. doi: 10.1016/j.biomaterials.2011.09.078.
84. Le Blanc, K., and Pittenger, M. (2005). Mesenchymal stem cells: progress toward promise. Cytotherapy 7, 36-45. doi: 10.1080/14653240510018118.
85. Lecker, S. H., Solomon, V., Price, S. R., Kwon, Y. T., Mitch, W. E., and Goldberg, A. L. (1999). Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J. Clin. Invest. 104, 1411-1420. doi: 10.1172/JCI7300.
86. Le Grand, F., Jones, A. E., Seale, V., Scime, A., and Rudnicki, M. A. (2009). Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell 4, 535-547. doi: 10.1016/j.stem.2009.03.013.
87. Leist, M., Bremer, S., Brundin, P., Hescheler, J., Kirkeby, A., Krause, K. H., et al. (2008). The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. ALTEX 25, 163-190.
88. Li, Z. F., Shelton, G. D., and Engvall, E. (2005). Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality. Am J Pathol 166, 491-497. doi: 10.1016/S0002-9440(10)62271-7.
89. Lian, Q., Zhang, Y., Zhang, J., Zhang, H. K., Wu, X., Zhang, Y., et al. (2010). Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121, 1113-1123. doi: 10.1161/CIRCULATIONAHA.109.898312.
90. Lin, T., Chao, C., Saito, S., Mazur, S. J., Murphy, M. E., Appella, E., et al. (2005). p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat. Cell Biol. 7, 165-171. doi: 10.1038/ncb1211.
91. Lutolf, M. P., Doyonnas, R., Havenstrite, K., Koleckar, K., and Blau, H. M. (2009a). Perturbation of single hematopoietic stem cell fates in artificial niches. Integr. Biol. (Camb.) 1, 59-69. doi: 10.1039/b815718a.
92. Lutolf, M. P., Gilbert, P. M., and Blau, H. M. (2009b). Designing materials to direct stem-cell fate. Nature 462, 433-441. doi: 10.1038/nature08602.
93. Lutolf, M. P., and Hubbell, J. A. (2005). Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23, 47-55. doi: 10.1038/nbt1055.
94. Madec, A. M., Mallone, R., Afonso, G., Abou Mrad, E., Mesnier, A., Eljaafari, A., et al. (2009). Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 52, 1391-1399. doi: 10.1007/s00125-009-1374-z.
95. Matzuk, M. M., Lu, N., Vogel, H., Sellheyer, K., Roop, D. R., and Bradley, A. (1995). Multiple defects and perinatal death in mice deficient in follistatin. Nature 374, 360-363. doi: 10.1038/374360a0.
96. Mccarthy, J. J., Esser, K. A., and Andrade, F. H. (2007). MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse. Am. J. Physiol. Cell Physiol. 293, C451-C457. doi: 10.1152/ajpcell.00077.2007.
97. Mccroskery, S., Thomas, M., Maxwell, L., Sharma, M., and Kambadur, R. (2003). Myostatin negatively regulates satellite cell activation and self-renewal. J. Cell Biol. 162, 1135-1147. doi: 10.1083/jcb.200207056.
98. Mcfarlane, C., Hennebry, A., Thomas, M., Plummer, E., Ling, N., Sharma, M., et al. (2008). Myostatin signals through Pax7 to regulate satellite cell self-renewal. Exp. Cell Res. 314, 317-329. doi: 10.1016/j.yexcr.2007.09.012.
99. Mcnally, E. M., Ly, C. T., Rosenmann, H., Mitrani Rosenbaum, S., Jiang, W., Anderson, L. V., et al. (2000). Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am. J. Med. Genet. 91, 305-312. doi: 10.1002/(SICI)1096-8628(20000410)91:4%3C305::AID-AJMG12%3E3.0.CO;2-S.
100. Mcpherron, A. C., Lawler, A. M., and Lee, S. J. (1997). Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83-90. doi: 10.1038/387083a0.
101. Mendell, J. R., Kissel, J. T., Amato, A. A., King, W., Signore, L., Prior, T. W., et al. (1995). Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333, 832-838. doi: 10.1056/NEJM199509283331303.
102. Mizuno, Y., Chang, H., Umeda, K., Niwa, A., Iwasa, T., Awaya, T., et al. (2010). Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J. 24, 2245-2253. doi: 10.1096/fj.09-137174.
103. Montarras, D., Morgan, J., Collins, C., Relaix, F., Zaffran, S., Cumano, A., et al. (2005). Direct isolation of satellite cells for skeletal muscle regeneration. Science 309, 2064-2067. doi: 10.1126/science.1114758.
104. Moon, S. Y., Park, Y. B., Kim, D. S., Oh, S. K., and Kim, D. W. (2006). Generation, culture, and differentiation of human embryonic stem cells for therapeutic applications. Mol. Ther. 13, 5-14. doi: 10.1016/j.ymthe.2005.09.008.
105. Morrison, S. J., and Kimble, J. (2006). Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441, 1068-1074. doi: 10.1038/nature04956.
106. Nakatani, M., Takehara, Y., Sugino, H., Matsumoto, M., Hashimoto, O., Hasegawa, Y., et al. (2008). Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J. 22, 477-487. doi: 10.1096/fj.07-8673com.
107. Negroni, E., Riederer, I., Chaouch, S., Belicchi, M., Razini, P., Di Santo, J., et al. (2009). In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study. Mol. Ther. 17, 1771-1778. doi: 10.1038/mt.2009.167.
108. Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., and Terzic, A. (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120, 408-416. doi: 10.1161/CIRCULATIONAHA.109.865154.
109. Nemeth, K., Leelahavanichkul, A., Yuen, P. S., Mayer, B., Parmelee, A., Doi, K., et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 42-49. doi: 10.1038/nm.1905.
110. Nesti, L. J., Jackson, W. M., Shanti, R. M., Koehler, S. M., Aragon, A. B., Bailey, J. R., et al. (2008). Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J. Bone Joint Surg. Am. 90, 2390-2398. doi: 10.2106/JBJS.H.00049.
111. Ohsawa, Y., Hagiwara, H., Nakatani, M., Yasue, A., Moriyama, K., Murakami, T., et al. (2006). Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition. J. Clin. Invest. 116, 2924-2934. doi: 10.1172/JCI28520.
112. O'rourke, J. R., Georges, S. A., Seay, H. R., Tapscott, S. J., Mcmanus, M. T., Goldhamer, D. J., et al. (2007). Essential role for Dicer during skeletal muscle development. Dev. Biol. 311, 359-368. doi: 10.1016/j.ydbio.2007.08.032.
113. Park, I. H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., et al. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146. doi: 10.1038/nature06534.
114. Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., and Sweeney, H. L. (1993). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. U.S.A. 90, 3710-3714. doi: 10.1073/pnas.90.8.3710.
115. Price, F. D., Kuroda, K., and Rudnicki, M. A. (2007). Stem cell based therapies to treat muscular dystrophy. Biochim. Biophys. Acta 1772, 272-283. doi: 10.1016/j.bbadis.2006.08.011.
116. Rafei, M., Birman, E., Forner, K., and Galipeau, J. (2009a). Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Mol. Ther. 17, 1799-1803. doi: 10.1038/mt.2009.157.
117. Rafei, M., Campeau, P. M., Aguilar-Mahecha, A., Buchanan, M., Williams, P., Birman, E., et al. (2009b). Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J. Immunol. 182, 5994-6002. doi: 10.4049/jimmunol.0803962.
118. Ratajczak, J., Miekus, K., Kucia, M., Zhang, J., Reca, R., Dvorak, P., et al. (2006). Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20, 847-856. doi: 10.1038/sj.leu.2404132.
119. Reubinoff, B. E., Itsykson, P., Turetsky, T., Pera, M. F., Reinhartz, E., Itzik, A., et al. (2001). Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 19, 1134-1140. doi: 10.1038/nbt1201-1134.
120. Riordan, N. H., Chan, K., Marleau, A. M., and Ichim, T. E. (2007). Cord blood in regenerative medicine: do we need immune suppression? J. Transl. Med. 5, 8. doi: 10.1186/1479-5876-5-8.
121. Rohwedel, J., Maltsev, V., Bober, E., Arnold, H. H., Hescheler, J., and Wobus, A. M. (1994). Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev. Biol. 164, 87-101. doi: 10.1006/dbio.1994.1182.
122. Rosner, M. H., Vigano, M. A., Ozato, K., Timmons, P. M., Poirier, F., Rigby, P. W., et al. (1990). A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345, 686-692. doi: 10.1038/345686a0.
123. Rothenfluh, D. A., Bermudez, H., O'neil, C. P., and Hubbell, J. A. (2008). Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. Nat. Mater. 7, 248-254. doi: 10.1038/nmat2116.
124. Rouger, K., Larcher, T., Dubreil, L., Deschamps, J. Y., Le Guiner, C., Jouvion, G., et al. (2011). Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs. Am. J. Pathol. 179, 2501-2518. doi: 10.1016/j.ajpath.2011.07.022.
125. Sacco, A., Doyonnas, R., Kraft, P., Vitorovic, S., and Blau, H. M. (2008). Self-renewal and expansion of single transplanted muscle stem cells. Nature 456, 502-506. doi: 10.1038/nature07384.
126. Sakurai, H., Inami, Y., Tamamura, Y., Yoshikai, T., Sehara-Fujisawa, A., and Isobe, K. (2009). Bidirectional induction toward paraxial mesodermal derivatives from mouse ES cells in chemically defined medium. Stem Cell Res. 3, 157-169. doi: 10.1016/j.scr.2009.08.002.
127. Sambasivan, R., and Tajbakhsh, S. (2007). Skeletal muscle stem cell birth and properties. Semin. Cell Dev. Biol. 18, 870-882. doi: 10.1016/j.semcdb.2007.09.013.
128. Sampaolesi, M., Blot, S., D'antona, G., Granger, N., Tonlorenzi, R., Innocenzi, A., et al. (2006). Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444, 574-579. doi: 10.1038/nature05282.
129. Sandri, M. (2008). Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23, 160-170. doi: 10.1152/physiol.00041.2007.
130. Sarig, R., Baruchi, Z., Fuchs, O., Nudel, U., and Yaffe, D. (2006). Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. Stem Cells 24, 1769-1778. doi: 10.1634/stemcells.2005-0547.
131. Schiaffino, S., Sandri, M., and Murgia, M. (2007). Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) 22, 269-278. doi: 10.1152/physiol.00009.2007.
132. Serra, F., Quarta, M., Canato, M., Toniolo, L., De Arcangelis, V., Trotta, A., et al. (2012). Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs. Muscle Nerve 46, 773-784. doi: 10.1002/mus.23432.
133. Serrano, A. L., and Munoz-Canoves, P. (2010). Regulation and dysregulation of fibrosis in skeletal muscle. Exp. Cell Res. 316, 3050-3058. doi: 10.1016/j.yexcr.2010.05.035.
134. Sherwood, R. I., Christensen, J. L., Conboy, I. M., Conboy, M. J., Rando, T. A., Weissman, I. L., et al. (2004). Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 119, 543-554. doi: 10.1016/j.cell.2004.10.021.
135. Shi, X., and Garry, D. J. (2006). Muscle stem cells in development, regeneration, and disease. Genes Dev. 20, 1692-1708. doi: 10.1101/gad.1419406.
136. Skottman, H., Dilber, M. S., and Hovatta, O. (2006). The derivation of clinical-grade human embryonic stem cell lines. FEBS Lett. 580, 2875-2878. doi: 10.1016/j.febslet.2006.03.083.
137. Smythe, G. M., Fan, Y., and Grounds, M. D. (2000). Enhanced migration and fusion of donor myoblasts in dystrophic and normal host muscle. Muscle Nerve 23, 560-574. doi: 10.1002/(SICI)1097-4598(200004)23:4%3C560::AID-MUS16%3E3.3.CO;2-7.
138. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., et al. (2009). Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977. doi: 10.1016/j.cell.2009.02.013.
139. Song, H. Y., Lee, M. J., Kim, M. Y., Kim, K. H., Lee, I. H., Shin, S. H., et al. (2010). Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis. Biochim. Biophys. Acta 1801, 23-30. doi: 10.1016/j.bbalip.2009.08.011.
140. Song, Z., Cai, J., Liu, Y., Zhao, D., Yong, J., Duo, S., et al. (2009). Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 19, 1233-1242. doi: 10.1038/cr.2009.107.
141. Spiller, M. P., Kambadur, R., Jeanplong, F., Thomas, M., Martyn, J. K., Bass, J. J., et al. (2002). The myostatin gene is a downstream target gene of basic helix-loop-helix transcription factor MyoD. Mol. Cell Biol. 22, 7066-7082. doi: 10.1128/MCB.22.20.7066-7082.2002.
142. Strulovici, Y., Leopold, P. L., O'connor, T. P., Pergolizzi, R. G., and Crystal, R. G. (2007). Human embryonic stem cells and gene therapy. Mol. Ther. 15, 850-866.
143. Suuronen, E. J., Kuraitis, D., and Ruel, M. (2008). Improving cell engraftment with tissue engineering. Semin. Thorac. Cardiovasc. Surg. 20, 110-114. doi: 10.1053/j.semtcvs.2008.03.005.
144. Suzuki, K., Totsuka, M., Nakaji, S., Yamada, M., Kudoh, S., Liu, Q., et al. (1999). Endurance exercise causes interaction among stress hormones, cytokines, neutrophil dynamics, and muscle damage. J. Appl. Physiol. 87, 1360-1367.
145. Tagliafico, E., Brunelli, S., Bergamaschi, A., De Angelis, L., Scardigli, R., Galli, D., et al. (2004). TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts. J. Cell Sci. 117, 4377-4388. doi: 10.1242/jcs.01291.
146. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. doi: 10.1016/j.cell.2006.07.024.
147. Tamaki, T., Okada, Y., Uchiyama, Y., Tono, K., Masuda, M., Wada, M., et al. (2007). Clonal multipotency of skeletal muscle-derived stem cells between mesodermal and ectodermal lineage. Stem Cells 25, 2283-2290. doi: 10.1634/stemcells.2006-0746.
148. Tanaka, K. K., Hall, J. K., Troy, A. A., Cornelison, D. D., Majka, S. M., and Olwin, B. B. (2009). Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell 4, 217-225. doi: 10.1016/j.stem.2009.01.016.
149. Tedesco, F. S., Gerli, M. F., Perani, L., Benedetti, S., Ungaro, F., Cassano, M., et al. (2012). Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci. Transl. Med. 4, 140ra189. doi: 10.1126/scitranslmed.3003541.
150. Tedesco, F. S., Hoshiya, H., D'antona, G., Gerli, M. F., Messina, G., Antonini, S., et al. (2011). Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy. Sci. Transl. Med. 3, 96ra78. doi: 10.1126/scitranslmed.3002342.
151. Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., et al. (2000). Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J. Biol. Chem. 275, 40235-40243. doi: 10.1074/jbc.M004356200.
152. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147. doi: 10.1126/science.282.5391.1145.
153. Thomson, J. A., and Marshall, V. S. (1998). Primate embryonic stem cells. Curr. Top Dev. Biol. 38, 133-165. doi: 10.1016/S0070-2153(08)60246-X.
154. Tidball, J. G., and Villalta, S. A. (2010). Regulatory interactions between muscle and the immune system during muscle regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1173-R1187. doi: 10.1152/ajpregu.00735.2009.
155. Torrente, Y., Belicchi, M., Marchesi, C., Dantona, G., Cogiamanian, F., Pisati, F., et al. (2007). Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant. 16, 563-577. doi: 10.3727/000000007783465064.
156. Torrente, Y., Tremblay, J. P., Pisati, F., Belicchi, M., Rossi, B., Sironi, M., et al. (2001). Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J. Cell Biol. 152, 335-348. doi: 10.1083/jcb.152.2.335.
157. Tremblay, J. P., Malouin, F., Roy, R., Huard, J., Bouchard, J. P., Satoh, A., et al. (1993). Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2, 99-112.
158. Usas, A., and Huard, J. (2007). Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials 28, 5401-5406. doi: 10.1016/j.biomaterials.2007.09.008.
159. Vial, C., Zuniga, L. M., Cabello-Verrugio, C., Canon, P., Fadic, R., and Brandan, E. (2008). Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation. J. Cell. Physiol. 215, 410-421. doi: 10.1002/jcp.21324.
160. Villalta, S. A., Nguyen, H. X., Deng, B., Gotoh, T., and Tidball, J. G. (2009). Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet. 18, 482-496. doi: 10.1093/hmg/ddn376.
161. Voisin, L., Gray, K., Flowers, K. M., Kimball, S. R., Jefferson, L. S., and Vary, T. C. (1996). Altered expression of eukaryotic initiation factor 2B in skeletal muscle during sepsis. Am. J. Physiol. 270, E43-E50.
162. Wagner, K. R., Fleckenstein, J. L., Amato, A. A., Barohn, R. J., Bushby, K., Escolar, D. M., et al. (2008). A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann. Neurol. 63, 561-571. doi: 10.1002/ana.21338.
163. Wehling, M., Spencer, M. J., and Tidball, J. G. (2001). A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol. 155, 123-131. doi: 10.1083/jcb.200105110.
164. Whalen, R. G., Harris, J. B., Butler-Browne, G. S., and Sesodia, S. (1990). Expression of myosin isoforms during notexin-induced regeneration of rat soleus muscles. Dev. Biol. 141, 24-40. doi: 10.1016/0012-1606(90)90099-5.
165. Whittemore, L. A., Song, K., Li, X., Aghajanian, J., Davies, M., Girgenrath, S., et al. (2003). Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem. Biophys. Res. Commun. 300, 965-971. doi: 10.1016/S0006-291X(02)02953-4.
166. Wozniak, M. A., and Chen, C. S. (2009). Mechanotransduction in development: a growing role for contractility. Nat. Rev. Mol. Cell Biol. 10, 34-43. doi: 10.1038/nrm2592.
167. Xu, C., Inokuma, M. S., Denham, J., Golds, K., Kundu, P., Gold, J. D., and Carpenter, M. K. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19, 971-974. doi: 10.1038/nbt1001-971.
168. Ye, L., Chang, J. C., Lin, C., Sun, X., Yu, J., and Kan, Y. W. (2009). Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc. Natl. Acad. Sci. U.S.A. 106, 9826-9830. doi: 10.1073/pnas.0904689106.
169. Zhang, X., Stojkovic, P., Przyborski, S., Cooke, M., Armstrong, L., Lako, M., et al. (2006). Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 24, 2669-2676. doi: 10.1634/stemcells.2006-0377.
170. Zheng, B., Cao, B., Crisan, M., Sun, B., Li, G., Logar, A., et al. (2007). Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat. Biotechnol. 25, 1025-1034. doi: 10.1038/nbt1334.
171. Zhou, K., Zhang, H., Jin, O., Feng, X., Yao, G., Hou, Y., et al. (2008). Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell. Mol. Immunol. 5, 417-424. doi: 10.1038/cmi.2008.52.
172. Zhou, L., Porter, J. D., Cheng, G., Gong, B., Hatala, D. A., Merriam, A. P., et al. (2006). Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice. Neuromuscul. Disord. 16, 32-38. doi: 10.1016/j.nmd.2005.09.009.
173. Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I. H., et al. (2009). Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120, 1513-1523. doi: 10.1161/CIRCULATIONAHA.109.868885.